BIN2 Antikörper (AA 290-496) (Biotin)
-
- Target Alle BIN2 Antikörper anzeigen
- BIN2 (Bridging Integrator 2 (BIN2))
-
Bindungsspezifität
- AA 290-496
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BIN2 Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Bridging integrator 2 protein (290-496AA)
- Isotyp
- IgG
- Top Product
- Discover our top product BIN2 Primärantikörper
-
anti-Bridging Integrator 2 (BIN2) (AA 290-496) antibody
BIN2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bridging Integrator 2 (BIN2) (AA 14-42), (N-Term) antibodyBIN2 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB27307 unconjugated
anti-Bridging Integrator 2 (BIN2) (Internal Region) antibodyBIN2 Reaktivität: Human WB, ELISA, IHC, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bridging Integrator 2 (BIN2) (AA 359-408) antibodyBIN2 Reaktivität: Human, Kaninchen, Rind (Kuh), Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bridging Integrator 2 (BIN2) (AA 1-239) antibodyBIN2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bridging Integrator 2 (BIN2) (AA 1-244) antibodyBIN2 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Bridging Integrator 2 (BIN2) (Middle Region) antibodyBIN2 Reaktivität: Human, Ratte, Kaninchen, Rind (Kuh), Schwein, Hund, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BIN2 (Bridging Integrator 2 (BIN2))
- Andere Bezeichnung
- BIN2 (BIN2 Produkte)
- Synonyme
- BRAP-1 antikoerper, BIN2 antikoerper, bin2l antikoerper, wu:fi05e01 antikoerper, zgc:55758 antikoerper, bridging integrator 2 antikoerper, bridging integrator 2b antikoerper, BIN2 antikoerper, Bin2 antikoerper, bin2b antikoerper
- Hintergrund
-
Background: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.
Aliases: BIN2 antibody, BRAP1Bridging integrator 2 antibody, Breast cancer-associated protein 1 antibody
- UniProt
- Q9UBW5
-
